Rendement sur 1 an (CAGR)
-16.66%
Sanofi SA Exchange (PA, EUR)
SAN.PA
71.94
+0.34 (+0.47%)
HealthcareDrug Manufacturers - General
Loading...
Rendement sur 3 ans (CAGR)
-3.95%
Rendement sur 5 ans (CAGR)
-4.05%
Rendement sur 10 ans (CAGR)
-0.34%
Adobe 3e trimestre 2026 – Le sentiment du marché influence-t-il le prix ?
Lire plusCapitalisation boursière
86.45B
Cours/chiffre d'affaires
1.80
Valeur d'entreprise
139.60B
Cours/valeur comptable
1.24
Rendement du div
0.00%
Années de croissance
-
Croissance du div
-
Versement FCF
62.02%
Trailing P/E
12.79
PEG
-
P/E prévisionnel
7.94
Croissance EPS
-8.21%
Informations sur les actions
Qu'est-ce qu'une bourse ? Fonctionnement, acteurs, exemples
Lire plusGraphique boursier
Loading...
Données du prix des actions
| Ouverture | 72.30 |
| Max journalier | 73.04 |
| Min journalier | 71.87 |
| Volume journalier | 3.06M |
| Niveau record | 109.62 |
| Estimation des analystes sur 1 an | 94.06 |
| Beta | 0.28 |
| EPS (TTM) | 5.65 |
| Dividende par action | 0.00 |
| Date ex-div | 5 May 2026 |
| Prochaine date de bénéfices | 23 Apr 2026 |
Potentiel de baisse
Loading...
Données du potentiel de baisse
| SAN.PA | S&P500 | |
| Baisse de prix actuelle par rapport au niveau record | -34.37% | -2.03% |
| Baisse de prix actuelle la plus importante | -55.80% | -56.47% |
| Date de la baisse la plus importante | 10 Oct 2008 | 9 Mar 2009 |
| Baisse moyenne par rapport au record | -19.77% | -10.66% |
| Délai moyen pour nouveau record | 44 days | 12 days |
| Délai max pour nouveau record | 2908 days | 1805 days |
Actualite
Recursion Pharmaceuticals (NasdaqGS:RXRX) said Sanofi has exercised its option on the first immunology candidate in their collaboration, triggering a milestone payment. The option exercise moves the p...
18 octobre 2026
Regeneron's biggest growth driver still has plenty of fuel left in the tank.
17 octobre 2026
Vaccine stocks are cracking under intense selling pressure, and one small developer with no control over its own commercial fate is bearing the worst of it. Whether its big-pharma partner can change t...
16 octobre 2026
Regeneron Pharmaceuticals (REGN) shares have been in focus after the company reported quarterly revenue of US$4.29b, up 16.7% year on year. The results beat analyst expectations and have lifted the st...
15 octobre 2026
Sanofi (ENXTPA:SAN) reached a Letter of Intent with the pan-Canadian Pharmaceutical Alliance to broaden public coverage for Dupixent. The agreement targets expanded reimbursement for Dupixent across f...
15 octobre 2026
Regeneron Pharmaceuticals has seen its share price move around in recent years, and fresh trial results plus a major immunology alliance are back in focus. With the stock closing at US$778.36 and inve...
15 octobre 2026
Sanofi has seen its share price under pressure over recent years, and a key issue for investors now is how well that current price lines up with what the business earns. The stock has declined 16.1% o...
15 octobre 2026
Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index rising 2.3% and the S
15 octobre 2026
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) snapped a three-day winning streak on Thursday, surging as much as 17.9 percent intraday, after Sanofi finally pulled the trigger on the development of dru...
15 octobre 2026
Sanofi stock reaction to new immunology candidate Sanofi (ENXTPA:SAN) just optioned the first development candidate from its AI-driven collaboration with Recursion Pharmaceuticals, triggering a $10 mi...
15 octobre 2026